Promising examples in PD, such as alpha-synuclein species, lysosomal enzymes, markers of amyloid and tau pathology, and neurofilament light chain, are under investigation in the blood and CSF (Parnetti et al., 2019). This evidence concerns the gene NEFL and Parkinson disease.